Patent Assignment
Reel/Frame 037471/0445
Change of Name
Recorded: 2016-01-11
Pages: 3
Assignor
ALPINE BIOSCIENCES, INC.
Executed: 2014-08-08
Assignee
PROTOCELL THERAPEUTICS INC.
2601 4TH AVENUE, SUITE 500, C/O ONCOTHYREON INC., SEATTLE, WASHINGTON, 98121
Covered Property
(1)
Dibenzo[B,F][1,4]Oxazapine Compounds
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 9, 2008
From: BECKER, CYRUS; RUBENS, COURTNEY; ADAMS, JASON; PALME, MONICA
To: ARYX THERAPEUTICS, INC.
Reel/Frame 020927/0850 →
Security Agreement
Oct 18, 2010
From: ARYX THERAPEUTICS, INC.
To: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
Reel/Frame 025150/0379 →
Assignment of Assignor's Interest
May 16, 2012
From: ARYX THERAPEUTICS, INC.
To: ANDAMAN THERAPEUTICS, INC.
Reel/Frame 028221/0270 →
Merger
Jan 8, 2016
From: ANDAMAN THERAPEUTICS, INC.; ALPINE BIOSCIENCES, LLC
To: ALPINE BIOSCIENCES, INC.
Reel/Frame 037443/0316 →
Merger
Jan 8, 2016
From: AB ACQUISITION; ALPINE BIOSCIENCES, INC.
To: ALPINE BIOSCIENCES, INC.
Reel/Frame 037464/0155 →